1. Home
  2. TLF vs LGVN Comparison

TLF vs LGVN Comparison

Compare TLF & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tandy Leather Factory Inc.

TLF

Tandy Leather Factory Inc.

N/A

Current Price

$2.54

Market Cap

19.5M

ML Signal

N/A

Logo Longeveron Inc.

LGVN

Longeveron Inc.

N/A

Current Price

$2.53

Market Cap

21.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TLF
LGVN
Founded
1980
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.5M
21.4M
IPO Year
2006
2021

Fundamental Metrics

Financial Performance
Metric
TLF
LGVN
Price
$2.54
$2.53
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $61.25
AVG Volume (30 Days)
11.5K
★ 138.4K
Earning Date
11-09-2026
11-03-2026
Dividend Yield
★ 30.07%
N/A
EPS Growth
★ 1122.22
50.76
EPS
★ 0.08
N/A
Revenue
★ $76,324,000.00
$709,000.00
Revenue This Year
N/A
$46.15
Revenue Next Year
N/A
$396.46
P/E Ratio
$31.50
★ N/A
Revenue Growth
★ 2.60
N/A
52 Week Low
$2.20
$0.48
52 Week High
$3.36
$7.60

Technical Indicators

Market Signals
Indicator
TLF
LGVN
Relative Strength Index (RSI) 46.48 40.54
Support Level $2.52 $0.61
Resistance Level $2.69 $7.45
Average True Range (ATR) 0.13 0.34
MACD -0.02 -0.36
Stochastic Oscillator 15.20 7.92

Price Performance

Historical Comparison
TLF
LGVN

About TLF Tandy Leather Factory Inc.

Tandy Leather Factory Inc is a specialty retailers of leather and leathercraft-related items. Its primary line of business is the sale of leather, leather crafts, and related supplies. Its broad line of leather and related products includes leather, leatherworking tools, leather dyes and finishes, and do-it-yourself kits. Its products include Leather, tools, Hardware, Supplies, Kits, Books and Patterns, and Gift cards. The company sells its products primarily through company-owned stores and through orders generated from its global websites, and through direct account representatives in its commercial division. Geographically the company operates within the United States, and Canada. it generates the highest revenue from the United States.

About LGVN Longeveron Inc.

Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.

Share on Social Networks: